Drug intelligence / Profile preview

l-carnitine + glucose

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

**l-carnitine + glucose** is a combination of two naturally occurring compounds: l-carnitine, an amino acid derivative involved in mitochondrial fatty acid transport and energy metabolism, and glucose, a primary carbohydrate fuel source in human metabolism. This combination is sometimes investigated or administered as a dietary supplement or as part of nutritional support formulations, particularly in metabolic, diabetic, or exercise studies. L-carnitine facilitates the transport of long-chain fatty acids into mitochondria for beta-oxidation, which may contribute to improved glucose utilization, energy production, and enhanced mitochondrial function, especially in tissues requiring high energy (e.g., cardiac and skeletal muscle). Supplementation with l-carnitine (including in combination with glucose) has been studied for its effects on glycemic control, insulin sensitivity, lipid metabolism, and overall metabolic homeostasis in populations with type 2 diabetes, metabolic syndrome, obesity, and in athletic settings. Glucose is included as a rapid energy substrate and to stimulate insulin secretion, which can interact metabolically with l-carnitine's activity on energy metabolism and glucose disposal[1][2][3].

02

Targets

SLC7A1 (Cationic amino acid transporter 1)CPT2 (Carnitine O-palmitoyltransferase 2)SLC25A20 (Carnitine/acylcarnitine translocase)SLC22A5 (Organic cation/carnitine transporter 2)SLC27A1 (Long-chain fatty acid transport protein 1)

Beyond the preview

Go deeper on l-carnitine + glucose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on l-carnitine + glucose.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call